STAT

A system to allocate scarce ventilators and ICU beds gains traction for not counting any group out

Bracing for a surge of #Covid19 patients, hospitals and governments are grappling with an unimaginable question: If ventilators and intensive care unit beds must be rationed, who should get them?
Medical supplies are seen inside New York City's Jacob Javits Center, which has been converted into a field hospital amid the coronavirus pandemic.

Bracing for a surge of Covid-19 patients and facing shortages of the resources necessary to keep the sickest patients alive, hospitals and governments are grappling with the reality of having to answer an unimaginable question: If ventilators and intensive care unit beds must be rationed, who should get them?

Several states have already issued guidance recommending that hospitals exclude certain patient groups from such care, such as those with late-stage cancer or Alzheimer’s disease — and in doing so, sparked a storm of criticism, as well as . Professional societies and academic bioethicists are also putting forward . One, in particular, is gaining traction.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks